Saliva secretion in patients with allergic rhinitis

International Archives of Allergy and Immunology

Volumn 141, Issue 3, 2006, Pages 276-280

  Elad, Sharon ^a,b   Heisler, Stela ^a   Shlit, Meir ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Allergy; Fexofenadine; Loratadine; Saliva; Xerostomia

Indexed keywords

ANTIHISTAMINIC AGENT; FEXOFENADINE; LORASTINE; LORATADINE;

ADULT; ALLERGIC RHINITIS; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRY EYE; DRY SKIN; FEMALE; HUMAN; INCIDENCE; MALE; PERCEPTION; PRIORITY JOURNAL; SALIVARY GLAND FUNCTION; SALIVATION; SIALOMETRY; VISUAL ANALOG SCALE; XEROSTOMIA;

ADOLESCENT; ADULT; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; LORATADINE; MIDDLE AGED; PATIENT SATISFACTION; PILOT PROJECTS; RHINITIS; SALIVA; SALIVARY GLANDS; TERFENADINE; XEROSTOMIA;

EID: 33750149090     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095297     Document Type: Article

References (13)

1. Neville BW, Damm DD, Allen CM, Bouquot JE: Oral and Maxillofacial Pathology, ed 2. Philadelphia, Saunders, 2002.
2. Guggenheimer J, Moore PA: Xerostomia: etiology, recognition and treatment. J Am Dent Assoc 2003;134:61-69; quiz 118-119.
3. Goetz DW, Jacobson JM, Apaliski SJ, Repperger DW, Martin ME: Objective antihistamine side effects are mitigated by evening dosing of hydroxyzine. Ann Allergy 1991;67:448-454.
4. Scully C, Bagan JV: Adverse drug reactions in the orofacial region. Crit Rev Oral Biol Med 2004;15:221-239.
5. Van Ganse E, Kaufman L, Derde MP, Yernault JC, Delaunois L, Vincken W: Effects of antihistamines in adult asthma: a meta-analysis of clinical trials. Eur Respir J 1997;10:2216-2224.
6. Aventis Pharmaceuticals: Allegra Prescribing Information. http://products.sanofi-aventis.us/allegra/allegra.html.
7. Longman LP, McCracken CF, Higham SM, Field EA: The clinical assessment of oral dryness is a significant predictor of salivary gland hypofunction. Oral Dis 2000;6:366-370.
8. Sreebny LM, Valdini A, Yu A: Xerostomia. II. Relationship to nonoral symptoms, drugs, and diseases. Oral Surg Oral Med Oral Pathol 1989;68:419-427.
9. Henz BM, Metzenauer P, O'Keefe E, Zuberbier T: Differential effects of new-generation H1-receptor antagonists in pruritic dermatoses. Allergy 1998;53:180-183.
10. Liu H, Farley JM: Effects of first and second generation antihistamines on muscarinic induced mucus gland cell ion transport. BMC Pharmacol 2005;5:8.
11. Barnett A, Iorio LC, Kreutner W, Tozzi S, Ahn HS, Gulbenkian A: Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine. Agents Actions 1984;14:590-597.
12. Kaplan A: Allergy, ed 1. New York, Churchill Livingstone, 1985.
13. Mygind N: Essential Allergy. An Illustrated Text for Students and Specialists. Oxford, Blackwell Scientific Publications, 1986.